234 related articles for article (PubMed ID: 4672049)
1. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
Ciuca I; Bulandra R; Serbanesco A; Ninosu N
Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049
[No Abstract] [Full Text] [Related]
2. Parkinson's disease; modern treatment.
Tolosa E
Minn Med; 1973 Jun; 56(6):497-502. PubMed ID: 4575903
[No Abstract] [Full Text] [Related]
3. [Current medical treatment of Parkinsonian syndromes].
Cincă I; Bulandra R; Serbănesco A; Ninosu N
Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
[No Abstract] [Full Text] [Related]
4. [Present-day treatment of parkinsonism in the aged].
Siegfried J
Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1202-3. PubMed ID: 4754539
[No Abstract] [Full Text] [Related]
5. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes].
Kluzer G; Lampo B
Minerva Med; 1971 Oct; 62(82):4013-4. PubMed ID: 5125067
[No Abstract] [Full Text] [Related]
6. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes and their implications for rehabilitation].
Raspa EG; Paciaroni E; Saccomanno G
Minerva Med; 1971 Oct; 62(82):4031-5. PubMed ID: 5125073
[No Abstract] [Full Text] [Related]
7. L-dopa and amantadine for Parkinsonism.
Drug Ther Bull; 1970 Aug; 8(17):65-7. PubMed ID: 5480244
[No Abstract] [Full Text] [Related]
8. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
Ambrosetto C; Martinelli P
Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
[No Abstract] [Full Text] [Related]
9. [Association of L-dopa and other therapeutic methods in treatment of parkinsonian syndromes].
Mingrino S
Sist Nerv; 1970; 22(2):212-5. PubMed ID: 4926920
[No Abstract] [Full Text] [Related]
10. [Action of amantadine HCl alone and in combination with L-dopa on parkinsonism].
Danielczyk W; Korten JJ
Med Monatsschr; 1971 Oct; 25(10):472-9. PubMed ID: 5122447
[No Abstract] [Full Text] [Related]
11. Treatment of Parkinson's disease with amantadine and L-Dopa.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618
[No Abstract] [Full Text] [Related]
12. The management of parkinsonism.
N Z Med J; 1971 Jul; 74(470):36-7. PubMed ID: 5289750
[No Abstract] [Full Text] [Related]
13. [Attempt at treating parkinsonism with L-dopa and Artane].
Stelmasiak Z; Lackowska H; Maksymowicz B
Pol Tyg Lek; 1971 Aug; 26(34):1325-6. PubMed ID: 5110789
[No Abstract] [Full Text] [Related]
14. Drug therapy of parkinsonism.
Yahr MD; Duvoisin RC
N Engl J Med; 1972 Jul; 287(1):20-4. PubMed ID: 4555145
[No Abstract] [Full Text] [Related]
15. [Treatment of Parkinson's disease with amantadine].
Sigwald J; Raymondeaud C; Grégoire J
Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
[No Abstract] [Full Text] [Related]
16. [Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease].
Dzudza M; Dzudza D
Med Arh; 1974; 28(4):407-15. PubMed ID: 4613968
[No Abstract] [Full Text] [Related]
17. Administration of amandine to patients on optimum L-dopa dosage.
Fehling C
Acta Neurol Scand Suppl; 1972; 51():119-20. PubMed ID: 4514335
[No Abstract] [Full Text] [Related]
18. [Factors which influence infavourably l-dopa treatment].
Presthus J
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2115-6. PubMed ID: 4590071
[No Abstract] [Full Text] [Related]
19. Combined L-dopa and amantadine in Parkinsonism.
Pollock M; Jorgensen PB
Aust N Z J Med; 1972 Aug; 2(3):252-5. PubMed ID: 4564049
[No Abstract] [Full Text] [Related]
20. [Kr 339 in the treatment of parkinsonian tremor].
Iivanainen M
Duodecim; 1974; 90(8):590-6. PubMed ID: 4605767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
